Podocyte injury is a central mechanism in the pathogenesis of proteinuria. Prostaglandin E 2 (PGE 2 ) has been suggested to protect podocytes from cellular injury. Here we investigated whether PGE 2 -induced gene expression accounts for the protective role of PGE 2 in podocytes. Using a suppressive-subtractive hybridization method, we isolated a differentially expressed clone that was identified as Stra13, a recently described retinoic acid-inducible gene. PGE 2 , forskolin, and retinoic acid induced a time-dependent up-regulation of Stra13 mRNA and protein expression in podocytes. To test the function of Stra13 in podocytes, Stra13 was overexpressed by using retroviral gene transfer. Compared with control cells, cells overexpressing Stra13 showed markedly reduced NADPH-dependent superoxid anion generation. Furthermore, expression of heme oxygenase 1 (HO-1) was increased in podocytes overexpressing Stra13. HO-1 plays an important protective role in the defense against reactive oxygen species (ROS). After stimulation with exogenous ROS, Stra13-overexpressing podocytes were more resistant to oxidative stress than were control cells. Our data indicate that Stra13 may play an important protective role against oxidative stress in podocytes. ROS are involved in the pathogenesis of glomerular inflammation in several forms of glomerulonephritis. Therefore, knowledge about protective mechanisms may provide insight into new therapeutic strategies for glomerulopathies.
a hallmark of almost all glomerular diseases (5, 6) . The mechanisms by which podocytes are damaged are as yet incompletely understood, but an altered prostaglandin action seems to play a role in some glomerular diseases. Changes in prostaglandin actions have been observed in distinct glomerulopathies such as membranous nephropathy (7), toxin-induced glomerular injury (8) , and glomerulosclerosis that develops after subtotal renal ablation (9) . The precise functions of EP receptors in podocytes and other glomerular cell types have not been well characterized.
To better understand the function of PGE 2 in podocytes, we used a polymerase chain reactionbased suppressive-subtractive hybridization (PCR-SSH) method (10) to identify genes that are differentially changed by PGE 2 . We demonstrate here that Stra13, a recently identified retinoic acid-inducible gene of the basic helix-loop-helix type, is differentially expressed by PGE 2 in podocytes and that Stra13 controls important functions of the podocyte.
MATERIALS AND METHODS

Cell culture
Conditionally immortalized mouse podocytes were cultured as reported elsewhere (11) . In brief, podocytes were maintained in RPMI 1640 medium (Life Technologies, Eggenstein, Germany) supplemented with 5% FCS (Boehringer Mannheim, Mannheim, Germany), 100 kU/L penicillin, and 100 mg/L streptomycin (Life Technologies). For propagation under permissive conditions, podocytes were cultivated at 33°C on type I collagen (Biochrom, Berlin, Germany), and the culture medium was supplemented with 10 U/ml recombinant interferon γ to enhance expression of the T antigen. For induction of differentiation, podocytes were maintained on type I collagen at 37°C without interferon γ (nonpermissive conditions). Podocytes between passages 10 and 16 were used in all experiments. Cells were switched to media that contained 1% FCS 24 h before the experiments and then were exposed to various treatments.
PCR-SSH
PCR-SSH was performed according to the method recently described (10) . In brief, RNA was isolated from control cells and cells that had been stimulated with 1 µM PGE 2 for 1 h. cDNA synthesis from 1 µg of total RNA from each cell population was achieved with the SMART PCR cDNA synthesis kit (Clone Tech, Palo Alto, CA) and subsequent long-distance PCR. After column purification and RsaI digestion, the tester cDNA was divided into two portions, and each was ligated to a different cDNA adaptor. Driver cDNA was not ligated to an adaptor sequence. After two hybridization steps, differentially expressed cDNA populations were PCR amplified, with nested primers corresponding to the two different adaptor sequences. For further screening steps, a reverse-subtracted probe with the original tester cDNA as a driver and the driver cDNA as a tester was generated. The subtracted cDNA library was cloned into a 3.9-kb PCRTM 2.1 vector (TA Cloning Kit; Invitrogen, San Diego, CA). The transformed clones were spotted onto two duplicate nylon membranes. Screening was performed on nylon filters hybridized with a 32 PdCTP-labeled part of the forward-subtracted library, and a 32 P-dCTP-labeled part of the reversesubtracted library. Differentially expressed clones were further analyzed by virtual Northern blotting: cloned inserts were excised from the vector by EcoRI digestion, separated by agarose gel electrophoresis, and extracted from the gel (QIAEX; QIAGEN, Heidelberg, Germany). A total of 25 ng of cDNA was labeled with a 32 P-dCTP by random priming and used to analyze 500 ng of double-stranded cDNA from each control and PGE 2 -treated podocytes by virtual Northern analysis. Virtual Northern analysis showed that cDNA from one clone hybridized to a 2.9-kb transcript that was strongly up-regulated in cells that had been treated with PGE 2 . The insert was then sequenced with an automated ALF sequencer and identified as part of the mouse Stra13 cDNA sequence (accession number AF010305).
Gene expression array
Differential gene expression was tested by using the Atlas cDNA Expression Array Kit (Clontech, Heidelberg, Germany): 5 µg of RNA was mixed with 1 µl of 10 × primer mix and incubated at 70°C for 2 min, followed by incubation for another 2 min at 50°C. A sample of 8 µl of master mix, containing 2 µl of 5 × reaction buffer (250 mM Tris-HCl, pH 8.3; and 375 mM KCl; 15 mM MgCl 2 ), 1 µl of 10 × dNTP mix for dATP labeling (5 mM each dCTP, dGTP, and dTTP), 3.5 µl of 32 P-dATP (10 µCi/µl, Amersham Pharmacia Biotech GmbH, Freiburg, Germany), 0.5 µl of 100 mM dithiothreitol, and 1 µl of Moloney murine leukemia virus (M-MLV) reverse transcriptase (RT) (50 U/µl), was added to the RNA and primer mix. Samples for reverse transcription were incubated for 30 min at 50°C. The reaction was stopped with 1 µl of 10 × termination mix (0.1 M EDTA, pH 8.0; 1 mg/ml glycogen). Labeled cDNA was purified on CHROMA SPIN-200 DEPC-H 2 O columns (termination mix and CHROMA columns were purchased from Clontech). Hybridization was performed according to the manufacturer's manual. In brief, microarray membranes were placed into roller bottles, washed with deionized H 2 O, and prehybridized with 500 µg of sheared salmon testes DNA in ExpressHyb hybridization solution (Stratagene GmbH, Heidelberg, Germany) at 68°C for 30 min. Labeled cDNA probes (2-10 × 10 6 cpm) were mixed with 10 × denaturating solution (1 M NaOH; 10 mM EDTA) and incubated at 68°C for 20 min. C o t-1 DNA and 2 × neutralizing solution (1 M NaH 2 PO 4 , pH 7.0) were added to the cDNA probes, incubated for 10 min at 68°C, and transferred together with hybridization solution to the membranes. Membranes were hybridized overnight at 68°C, washed with prewarmed washing solutions, and wrapped in plastic wrap. Membranes were exposed to X-ray film (Biomax MS, Kodak, München, Germany) at -80°C with intensifying screens. For best evaluation, films were exposed for various time periods (from 12 h to 7 days).
Expression of retinoic acid receptor (RAR) mRNA in podocytes
RNA preparation, reverse transcription, and PCR amplification were performed according to the method described recently (10) . In brief, total RNA from cultured mouse podocytes was isolated with the acid guanidinium-thiocyanate-phenol-chloroform extraction method, and the amount of RNA was measured by spectrophotometry. For first-strand synthesis, 0.2 µg of total RNA was mixed in 5 × reverse transcription buffer containing 0.5 mM dNTP, 10 µM random primers, 10 mM dithiothreitol, 4 U RNase inhibitor, and 20 U M-MLV RT (RT was also omitted to control for the amplification of contaminating DNA). Reverse transcription was performed at 42°C for 1 h followed by transcription at 95°C for 5 min. PCR was performed in duplicates in a total volume of 20 µl, each sample containing 4 µl of reverse transcription reaction and 16 µl of PCR master mixture containing 10 pmol each of sense and antisense primers and 1.0 U Taq DNA polymerase. The cycle profile included denaturation for 60 s at 94°C, annealing for 60 s at 60°C (RAR-α), 62°C (RAR-β), 60°C (RAR-γ), or 58°C (RXR-α), and at varying temperatures (RXR-β and RXR-γ). Extension lasted 60 s at 72°C. The numbers of cycles of PCR were as follows:
RAR-α, 32; RAR-β, 40; RAR-γ, 32; RXR-γ 32; and RXR-β and RXR-α, each 40. The amplification products of 10 µl from each PCR reaction were separated on appropriate agarose gels, stained with ethidium bromide, and visualized by use of UV irradiation. PCR amplification of RT reactions without RT revealed no PCR product, thereby excluding amplification of genomic DNA. The primers that were used are shown in Table 1 .
Northern analysis of Stra13 mRNA in podocytes
Northern analysis of the expression of Stra13 was performed according to the method recently described (10) . In brief, RNA was isolated by acid phenol extraction. RNA (10 µg/lane) was separated by size in agarose/formaldehyde gels and transferred to Hybond nylon membranes (Pharmacia, Freiburg, Germany). Stra13 cDNA was labeled with 32 P-dCTP by use of a random primer labeling kit (Stratagene). After analysis of the Stra13 signal, blots were rehybridized to a 32 P-dCTP-labeled probe for the housekeeping gene GAPDH, to control for variation in loading and transfer among samples.
Antisense experiments
Antisense experiments were performed with morpholino antisense oligonucleotides (AS). The following oligonucleotides were used: Stra13 AS: 5'-GATCCGTTCCATGATGCGGCGAGCA-3'; control oligonucleotide (inverted antisense sequence): 5'-ACGAGCGGCGTAGTACCTTGCCTAG-3' (Gene Tools, Pilomath, OR). Untransfected mouse podocytes were grown in six-well plates to 60-70% confluency. A sample of 16.8 µl of antisense oligonucleotide (300 nmol) and control oligonucleotide (300 nmol), 566.4 µl of sterile water, and 16.8 µl of ethoxylated-polyethylenimine (EPEI) (200 µM) were mixed and incubated for 20 min at room temperature. After addition of 5.6 ml of serum-free cell medium to the antisense-EPEI mixture, cells were incubated for 3 h with the antisense-oligonucleotide complex. The antisenseoligonucleotide complex was replaced by fresh serum-containing medium, and the cells were incubated for 16 h under standard incubator conditions. Thereafter, cells were harvested for Western blot experiments and measurement of NADPH oxidase activity.
Plasmids and construction of viral vectors
The Stra13 cDNA-containing plasmid (pLXSN-Stra13-IRES.gfp) used to generate the retroviral transfer vector was generated by using standard cloning techniques. The plasmid pLXSN was kindly provided by D. Miller (Fred Hutchinson Cancer Research Center, Seattle, WA). The plasmids pMD-G and pMD-gp were a kind gift of R. Mulligan (Harvard Medical School, Boston, MA).
Cell culture, virus production, and transduction
The retroviral vector was produced by cotransfection of HEK 293T cells with three plasmids (2.5 µg of pMD-G, 7.5 µg of pMD-gp, and 10 µg of the retroviral transfer vector) by using the calcium phosphate method. The supernatant was harvested, centrifuged to remove cellular debris, and filtered. Cells were infected in the presence of 8 µg/ml Polybrene for 4 h and were selected 3-4 days after viral transduction in neomycin (500 µg/ml) to achieve 100% positive cells. No clonal isolation was performed to ensure random insertion of the retroviral vector into podocyte DNA. Virus transduction and transgene expression were monitored by fluorescent microscopy of the coexpressed green fluorescent protein and Western blot analysis.
Immunhistochemical analysis
Fixation and preparation of tissue for immunohistochemical analyses were performed with standard techniques. In brief, mouse kidneys were perfused with 5 ml of cold (4°C) PBS followed by 5 ml of 4% paraformaldehyde. After removal of kidneys, they were incubated for 24 h at 4°C in 4% paraformaldehyde solution, embedded in paraffin, and cut into slices 5-7 µm thick. Slices were deparaffinized in xylol for 1 h, gradually hydrated through graded alcohol solutions (100 to 70%), and washed in deionized water. After incubation in 1% H 2 O 2 for 30 min, slices were rehydrated with PBS, and antigen unmasking was performed by incubation of the slices in 0.05% proteinase K solution for 10 min or boiling in 10 mM citrate buffer (pH 6) 2 × 10 min. Blocking was performed using a 1% BSA solution for 10 min. Thereafter, sections were incubated for 24 h, in a humidified chamber at 4°C, with antibodies against Stra13 or synaptopodin (rabbit anti-Stra13, a generous gift from Dr. Chambon, Strasbourg, France; mouse anti-synaptopodin, Progen Biotechnik GmbH, Heidelberg, Germany). The slices were washed extensively with PBS and incubated for 45 min with a secondary antibody using a commercially available ABC kit (Vectastain ABC-Peroxidase Kit, Vector Laboratories, Burlingame, CA). Slices were washed with PBS, incubated with avidin-biotin for 45 min, and stained with 3-amino-9 ethylcarbazole (red) or Fast Blue BB salt with naphthol AS-MX phosphate (blue) (Sigma-Aldrich, Steinheim, Germany). Sections were examined with a conventional light microscope (Zeiss LSM 510) and were photographed with a digital camera. Negative controls were obtained by elimination or heat denaturation of the primary antibodies. For double-labeling experiments, serial ultrathin sections of mouse kidneys were stained with anti-Stra13 antibodies or anti-synaptopodin antibodies, and pictures of the same glomerulus were projected on top of each other by using commercially available computer programs.
Measurement of NADPH oxidase activity
Podocytes were rinsed twice with ice-cold PBS, scraped from the wells, and resuspended in 2 ml of Krebs buffer. The pellet obtained after centrifugation at 750g for 5 min at 4°C was resuspended in 1.5 ml of fresh Krebs buffer (pH 7.35; containing 99 mM NaCl, 4.7 mM KCl, 1.8 mM CaCl 2 , 1.2 mM MgCl 2 , 25 mM NaHCO 3 , 1.03 mM K 2 HPO 4 , 20 mM sodium 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES], and 11.1 mM glucose). Cells were centrifuged as above, and the pellet was then resuspended in 0.6 ml of Krebs buffer. The luminescence buffer contained 5 µM lucigenin and 0.1 mM NADPH as substrate. To calculate the amount of superoxide produced, total counts were generated by integrating the area under the signal curve. These values were compared with those from a standard curve, which was generated by using xanthine plus xanthine oxidase (X/XO) as described previously (12) . Superoxide generation was expressed as nmol O 2 − generated per mg of cellular protein per minute, as described earlier (13) . Protein content of the cell suspension was measured with the Lowry method.
Western blotting
Western blotting was performed by using standard techniques. In brief, cells were washed once with PBS and scraped with lysis buffer containing 2 mM EDTA, 2 mM EGTA, 100 mM NaCl, 20 mM Tris, 0.1% sodium dodecyl sulfate (SDS), 1% NP-40, 2 mM phenylmethylsulfonyl fluoride, and proteinase inhibitor cocktail (Roche Diagnostics, Basel, Switzerland); and were then sonicated. The samples were resuspended in Laemmli sample buffer, boiled (5 min), and subjected to SDS-polyacrylamide gel electrophoresis and transfer electrophoresis. The transblots were stained with ponceau solution to prove that equal amounts of protein were loaded on the membrane and were probed with primary antibodies (rabbit anti-Stra13, rabbit anti-HO-1; Stressgen Biotechnologies, Hamburg, Germany), followed by peroxidase-labeled secondary antibodies (donkey anti-rabbit; Amersham Pharmacia, Piscataway, NJ), and were then detected by chemiluminescence detection reagents (ECL, Amersham Pharmacia).
Lactate dehydrogenase (LDH) release
Cultured mouse podocytes were grown on coated six-well dishes as described above. After addition of a defined amount of medium (2 ml) to each 6 well, X/XO (50 µM/50 mU/ml) or vehicle (H 2 O) was added for 4 h or 8 h, respectively. Then, the cell medium was collected, and the LDH content of each sample was analyzed with a standard automated analyzer. All six wells were washed once with PBS to remove cellular debris and were scraped with 1 ml of PBS. The protein content of the cell suspension was measured by using the Lowry method.
Statistical analyses
Data expressed as means ± SE were analyzed by ANOVA for repeated measures when comparing within groups and one-way ANOVA when comparing among groups; the t test was used for a two-group comparison. P < 0.05 was considered significant.
RESULTS
PGE 2 induced Stra13 mRNA expression in podocytes
To identify genes that are induced by PGE 2 , we used a PCR-based cDNA subtractive hybridization strategy to generate a cDNA library of genes that are differentially expressed by PGE 2 in podocytes. Seventy-seven clones from the differentially expressed cDNA library were further analyzed by differential screening, and eight clones generated an increased hybridization signal when hybridized to RNA from PGE 2 -treated podocytes compared with RNA from control cells. A 2.9-kb transcript that was highly up-regulated in podocytes stimulated with PGE 2 was selected from these eight clones. This cDNA clone was sequenced and identified by BLAST analysis as a fragment of the mouse Stra13 cDNA (accession number AF010305).
Stra13 mRNA and protein were up-regulated by PGE 2 and retinoic acid in podocytes
To further characterize the induction of Stra13 mRNA by PGE 2 , a time course of Stra13 mRNA expression in podocytes was investigated via Northern blotting. Expression of Stra13 mRNA in podocytes was markedly up-regulated after 1 h but had declined after 4 h of stimulation with PGE 2 (Fig. 1) . To ensure that Stra13 mRNA expression in response to PGE 2 results in a subsequent increase of protein expression, Western blot analyses were performed of the expression of Stra13 in 10 µM PGE 2 -treated podocytes, 1 µM forskolin-treated podocytes, and podocytes stimulated with vehicle (dimethyl sulfoxide [DMSO] ). Figure 2 shows that PGE 2 ( Fig.  2A) and forskolin (Fig. 2B) , both stimulators of intracellular cAMP production, induced an increase of Stra13 protein in podocytes after 1 h of stimulation. Stimulation of podocytes with PGE 2 for 2, 3, 4, 8, or 24 h did not increase Stra13 protein expression (data not shown). In contrast, the Ca 2+ ionophore A23187 (10 µM) did not influence the expression of Stra13 protein in podocytes, which indicated that cAMP may be the second messenger involved in Stra13 upregulation (n=3, data not shown).
Recently, Stra13 was identified as a retinoic acid-inducible gene in neuronal cells (14) . To confirm this finding in the kidney, mouse podocytes were stimulated with 10 µM retinoic acid for 1, 4, 24, or 48 h. Interestingly, Stra13 protein expression was increased after 1 and 4 h but decreased after 48 h of stimulation (Fig. 2C and D) . Because Stra13 protein expression in the kidney has not been characterized, mouse kidneys in anesthetized mice were perfused for 1 h with either 10 µM PGE 2 or vehicle through a catheter placed in the infrarenal aorta. Immunohistochemical staining with antibodies against Stra13 revealed ubiquitous nuclear expression of Stra13 in the mouse kidney with only minimal expression in the glomerulus (Fig.  3A) . After stimulation with PGE 2 (Fig. 3B) , expression of Stra13 increased in both tubular and glomerular cells. Negative controls (Fig. 3C) revealed no appreciable staining. Serial ultrathin sections of a mouse kidney perfused for 1 h with 10 µM PGE 2 were stained with antibodies against Stra13 (red) and synaptopodin, a podocyte-specific protein (blue). To demonstrate colocalization of Stra13 and synaptopodin in mouse podocytes, pictures of the same glomerulus were merged by using Adobe Photoshop (Fig. 3D) .
Because nothing is known about the expression of RARs in podocytes, RT-PCR experiments were performed with selective primers (Table 1) recognizing known isoforms of mouse RARs and retinoid X receptors (RXRs). Figure 4 shows ethidium bromide-stained agarose gels with PCR products for the RAR isoforms RAR-α, RAR-β, and RAR-γ and for RXR-α. No products for the RXR isoforms RXR-β and RXR-γ were found (data not shown).
Stra13 reduced NADPH-dependent superoxide anion generation in podocytes
Stra13-deficient mice develop a defective T-cell activation and autoimmune glomerulopathy (15) . The mechanism for the development of autoimmune glomerulopathy in these mice has not been clarified. It has been suggested that the generation of reactive oxygen species (ROS) plays a major role in the pathogenesis of glomerulopathies and proteinuria (16) . Interestingly, activation of the NADPH oxidoreductase enzyme complex leading to generation of ROS has been shown in podocytes in vivo and in vitro (12, 16) . To test the hypothesis that Stra13 may be involved in the regulation of the cellular redox state of podocytes, we first generated a mouse podocyte cell line overexpressing Stra13. Figure 5A shows a Western blot analysis demonstrating the efficiency of Stra13 overexpression in podocytes compared with control cells transfected with vector only. The function of the NADPH oxidoreductase enzyme complex was then tested in podocytes overexpressing Stra13 and in control cells. Addition of 0.1 mM NADH as a substrate did not stimulate O 2 − production in either group of cells. In contrast, addition of 0.1 mM NADPH increased O 2 − production in control cells. This effect was markedly reduced in podocytes overexpressing Stra13 (Fig. 5B) .
Similar to the situation with cells overexpressing Stra13, untransfected podocytes, after stimulation with 0.1 mM NADPH as a substrate, showed a time-dependent decrease in O 2 − production caused by PGE 2 (Fig. 6A ) and retinoic acid (Fig. 6B) . To prove that Stra13 is responsible for the effects of retinoic acid on NADPH oxidase activity, antisense experiments with Stra13 AS were performed. First, the specificity of anti-Stra13 AS and control antisense oligonucleotides (CoAS) on Stra13 protein expression was tested (Fig. 7A) . Stimulation of untransfected mouse podocytes with 1 µM forskolin for 45 min induced the known up-regulation of Stra13 compared with vehicle-stimulated control cells. Pretreatment of mouse podocytes with CoAS slightly reduced total forskolin-induced Stra13 expression. Pretreatment of mouse podocytes with anti-Stra13 AS reduced forskolin-induced Stra13 expression compared with experiments with CoAS. To show linkage between RAR and its effect on NADPH oxidase activity via Stra13, untransfected mouse podocytes were preincubated with CoAS or AS. Preincubation with CoAS did not influence retinoic acid-induced inhibition of NADPH oxidase activity. In contrast, preincubation with AS partially reversed retinoic acid-induced inhibition of NADPH oxidase activity (Fig. 7B) .
Stra13 regulated the expression of heme oxygenase 1 (HO-1)
To further characterize cellular functions of Stra13, gene expression arrays were performed using mRNA from podocytes overexpressing Stra13 and control cells. Figure 8A shows that mRNA expression for HO-1 was up-regulated in cells overexpressing Stra13. To confirm these data, Western blot experiments were performed with cells overexpressing Stra13 and control cells (Fig. 8B ). We found a significant increase in HO-1 expression in cells overexpressing Stra13. To test the ability of PGE 2 and retinoic acid to induce HO-1 expression in untransfected podocytes, we performed Western blots with untransfected podocytes stimulated with either 10 µM PGE 2 or 10 µM retinoic acid. PGE 2 did not induce HO-1 expression in untransfected podocytes (data not shown). In contrast, retinoic acid induced a time-dependent increase after 24 h of stimulation (Fig. 9 ).
Stra13-overexpressing cells resisted oxidative stress-mediated cell death
Recent data indicate that cells overexpressing HO-1 resist oxidative stress-mediated cell death (17) . To test the hypothesis that Stra13, through inhibition of the NADPH oxidoreductase enzyme complex and induction of HO-1, protects podocytes from oxidative stress, we stimulated Stra13-overexpressing podocytes and control cells with superoxide anions generated by the X/XO reaction. Our data show that LDH release, a measure of cytotoxicity, was significantly reduced in Stra13-overexpressing cells after stimulation with X/XO, both after 4 h (Fig. 10) and after 8 h (data not shown) of stimulation. In addition, significant morphological changes were found in control cells but not in Stra13-overexpressing cells at the time point of LDH measurement after 4 h (Fig. 10 ) or 8 h (data not shown) of stimulation with X/XO. To prove that the observed benefit under oxidative stress in Stra13-overexpressing cells can be linked directly to HO-1 production, we preincubated Stra13-overexpressing cells and control cells with 10 µM zinc protoporphyrin IX (ZnPP), an inhibitor of HO-1 induction, and 200 µM deferoxamine, a potent inhibitor of lipid peroxidation. Preincubation with ZnPP reversed the protective effect of Stra13 overexpression so that LDH release in control cells and that in Stra13-overexpressing cells no longer differed. Preincubation with deferoxamine did not influence the protective properties of Stra13 overexpression (Fig. 11) .
DISCUSSION
Stra13 has been found to be a retinoic acid-inducible gene of the basic helix-loop-helix family. It inhibits mesodermal and promotes neuronal differentiation of neuronal cells (14) . Recent studies suggest that Stra13 is a key regulator of lymphocyte activation and plays an important role in the maintenance of self-tolerance and for constraint of autoimmunity. Stra13-deficient mice exhibit defects in several phases of CD4 + T-cell activation and develop autoimmune diseases including an immune complex glomerulonephritis (15) . The precise mechanisms by which Stra13 regulates cellular functions are poorly understood. Here, we showed that expression of Stra13 can be induced by PGE 2 and retinoic acid in podocytes. Like PGE 2 , forskolin, a direct activator of adenylate cyclases, increased expression of Stra13, whereas augmenting the cytosolic free Ca 2+ concentration by a Ca 2+ ionophore had no effect. This result indicates that PGE 2 increases Stra13 expression via modulation of intracellular cAMP levels. A cAMP-mediated increase of Stra13 expression has been observed in other cell types (18) . Western blot analysis showed that PGE 2 induced a rapid and very transient increase of Stra13 protein expression, which peaked at about 1 h, whereas retinoic acid had a more prolonged effect on Stra13 protein expression, with a peak at 1 h and a still significant increase after 4 h. Immunohistochemical staining showed that Stra13 was mainly localized in tubular cells with only minor expression in glomerular cells. However, stimulation with PGE 2 led to a marked increase of Stra13 expression, both in tubular cells and in glomerular cells including podocytes.
ROS production has been implicated in the pathogenesis of several diseases such as cancer, diabetes mellitus, atherosclerosis, ischemia, and glomerulonephritis (19) (20) (21) . Podocytes are not only the target but also the source of ROS. Activation of the NADPH oxidase, a major enzymatic source of ROS in podocytes, plays a critical role in the pathogenesis of proteinuria in Heymann nephritis (16) . Here, we showed that NADPH-dependent O 2 − generation was inhibited in Stra13-overexpressing podocytes, which suggests an important link between Stra13 expression and the cellular redox state of podocytes. As in Stra13-overexpressing podocytes, Stra13 induction through either PGE 2 or retinoic acid caused a time-dependent inhibition of NADPH oxidasedependent O 2 − production in podocytes. In comparison to the strong effect of retinoic acid on O 2 − production, the effect of PGE 2 was much smaller. This finding may be explained by the smaller and more transient stimulation of Stra13 expression induced by PGE 2 .
Retinoic acid is essential for embryonic development and maintenance of differentiation, i.e., epithelial differentiation requires retinoic acid (22) . Furthermore, retinoic acid has been implicated as an inhibitor of glomerular injury (23) . The effects of retinoic acid are mediated by specific nuclear receptors, namely, RAR and RXR, which are further subdivided into isotypes α-, β-, and γ (23). The RARs are activated by the prototypic retinoids all-trans-retinoic acid and 9-cis-retinoic acid. In contrast, the RXRs are activated exclusively by 9-cis-retinoic acid (22) . RXR isoforms are mainly localized in the proximal and distal tubules, but not in glomeruli (24, 25) . Knowledge about the localization and function of RARs in the glomerulus is limited. All RAR subtypes were expressed in cultured mesangial cells. There, retinoic acid has several protective functions: it inhibits mesangial cell proliferation (26) , it prevents ROS-mediated mesangial cell death (27) , and it inhibits the constitutive expression of mesangial cell chemokines such as monocyte chemoattractant protein 1 (MCP-1) (28). Our data indicate that podocytes express the RAR isotypes α-, β-, and γ and the RXR isotype α. Because retinoic acid stimulated the expression of Stra13 and induced potent inhibition of O 2 − generation in podocytes, retinoic acid may at least in part contribute to the reduction of proteinuria during glomerular injury.
Multiple factors such as hypoxia, ROS, and cytokines can induce expression of HO-1, a protein also called heat shock protein-32 (29) . The inducibility of HO-1 by ROS in many tissues has rendered HO-1 a good indicator of cellular oxidative stress (30) (31) (32) . Heme oxygenases play an important antioxidative and anti-inflammatory role via degradation of heme to biliverdin or bilirubin, CO, and Fe 2+ (30) . HO-1 knockout cells demonstrate an increased susceptibility to apoptosis in response to stress. In contrast, transfection of HO-1 into cells protects against stressinduced cell death (17) . HO-1 has also been implicated in many clinically important diseases, including atherosclerosis, hypertension, acute renal injury, diabetic nephropathy, toxic nephropathy, and nephrotoxic serum nephritis, among others (32, 33) . Up-regulation of HO-1 has been reported during glomerular injury, and stimulation of expression of HO-1 by treatment with hemin inhibits proteinuria (34, 35) . Other studies suggest that that HO-1 acts as a protective agent not only during the acute phase of nephrotoxicity but also during chronic inflammatory damage induced by heme proteins (32) . HO-1 has also been shown to suppress inflammatory responses, mediated in part by down-regulating the expression of proinflammatory molecules such as nuclear factor-κB and MCP-1 (28).
Our data demonstrate that HO-1 expression was increased in Stra13-overexpressing podocytes. In addition, retinoic acid caused a long-lasting increase of HO-1 expression, whereas PGE 2 had no significant effect. The inability of PGE 2 to induce HO-1 may be explained by its weaker and more transient effect on Stra13 expression in comparison to retinoic acid. Thus, by reducing O 2 − generation and increasing HO-1 expression, Stra13 may exert important protective effects on podocytes. To test this hypothesis, podocytes were treated with high concentrations of ROS, and ROS-induced cell death was measured via toxic LDH release. Stra13-overexpressing podocytes exhibited less cell damage in response to ROS, which suggests that Stra13 serves as an inhibitor of cell damage in podocytes.
In summary, we demonstrated that Stra13 is induced by PGE 2 and retinoic acid in podocytes and that it exerts important effects on the cellular redox state in this cell type. Our data provide a new explanation of how PGE 2 and retinoic acid inhibit oxidative stress and cell injury in podocytes. 
